Crystalline peptide epoxyketone immunoproteasome inhibitor

Details for Australian Patent Application No. 2011245630 (hide)

Owner Onyx Therapeutics, Inc. Phiasivongsa, P.

Inventors Phiasivongsa, Pasit

Agent Shelston IP

Pub. Number AU-A-2011245630

PCT Pub. Number WO2011/136905

Priority 61/321,577 07.04.10 US

Filing date 6 April 2011

Wipo publication date 3 November 2011

International Classifications

C07K 5/06 Peptides having up to four amino acids in a fully defined sequence

Event Publications

1 November 2012 PCT application entered the National Phase

  PCT publication WO2011/136905 Priority application(s): WO2011/136905

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011245653-Secure and efficient login and transaction authentication using iphones and other smart mobile communication devices

2011245626-Free-standing wall arrangement and methods